Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. (Q37944488)

25 August 2017

title

Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. (English)

1 reference

25 August 2017

1 reference

9

1 reference

25 August 2017

8

David R Bangsberg

1 reference

25 August 2017

6

Angela Kaida

1 reference

25 August 2017

7

Cari L Miller

1 reference

25 August 2017

Cathy M Puskas

1

1 reference

25 August 2017

Jamie I Forrest

2

1 reference

25 August 2017

Surita Parashar

3

1 reference

25 August 2017

Kate A Salters

4

1 reference

25 August 2017

Angela M Cescon

5

1 reference

25 August 2017

publication date

1 December 2011

1 reference

25 August 2017

published in

Current HIV/AIDS reports

1 reference

25 August 2017

volume

8

1 reference

25 August 2017

issue

4

1 reference

25 August 2017

page(s)

277-287

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-011-0098-0

25 August 2017

exact match

0 references

cites work

Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Factors associated with adherence to antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Sleep disturbance and depression as barriers to adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Prediction of adherence to antiretroviral therapy: can patients' gender play some role? An Italian pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Social stigma concerns and HIV medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Stressful life events and adherence in HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Medication adherence for HIV positive women caring for children: in their own words

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Hospitalized HIV-infected patients in the HAART era: a view from the inner city

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Comparison of 3-drug versus 4-drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Successive switching of antiretroviral therapy is associated with high psychological and physical burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir, in treatment-experienced HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Perceived adverse effects of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Self-reported non-adherence to ART and virological outcome in a multiclinic UK study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Treatment as prevention--a double hat-trick

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Measuring adherence to highly active antiretroviral therapy: implications for research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Factors associated with non-adherence to antiretroviral therapy in the SUN study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Is patients' preferred involvement in health decisions related to outcomes for patients with HIV?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to HAART among HIV-infected persons in rural Louisiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to antiretroviral therapy: a survey of factors associated with medication usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

General health status and adherence to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Factors influencing adherence to highly active antiretroviral therapy in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

The patient-provider relationship and adherence to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥ 200 cells/μl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Patients' Answers to Simple Questions About Treatment Satisfaction and Adherence and Depression Are Associated with Failure of HAART: A Cross-Sectional Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

A Simple, Dynamic Measure of Antiretroviral Therapy Adherence Predicts Failure to Maintain HIV‐1 Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Adherence to treatment in Swedish HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-011-0098-0

Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples

21 January 2018

1 reference

12 December 2020

Study of the Validity of a Questionnaire to Assess the Adherence to Therapy in Patients Infected by HIV

1 reference

12 December 2020

Nonadherence among HIV-infected injecting drug users: the impact of social instability

1 reference

12 December 2020

Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients

1 reference

12 December 2020

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver

1 reference

12 December 2020

HIV treatment adherence and sexual functioning

1 reference

12 December 2020

Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill

1 reference

12 December 2020

Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse

1 reference

12 December 2020

Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes

1 reference

12 December 2020

Depressive Symptoms, Neurocognitive Impairment, and Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Persons

1 reference

12 December 2020

Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study

1 reference

12 December 2020

Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence

1 reference

12 December 2020

A qualitative study of persons who are 100% adherent to antiretroviral therapy

1 reference

12 December 2020

1 reference

12 December 2020

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients

1 reference

12 December 2020

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

1 reference

12 December 2020

Pill taking from the perspective of HIV-Infected women who are vulnerable to antiretroviral treatment failure

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women

1 reference

12 December 2020

Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients

1 reference

12 December 2020

HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women

1 reference

12 December 2020

10.1007/S11904-011-0098-0

Identifiers

DOI

1 reference

25 August 2017

1 reference